Machine Learning

New research reveals how stomach cancer cells hijack healthy tissue to build supportive 'nests' in distant organs, opening a new front in the war on metastasis.

The diabetes tech firm secures major funding for innovation and acquisitions, using a savvy financial strategy to protect current shareholder value.

With its transformative Lanteris acquisition complete, all eyes are on Intuitive Machines' upcoming financial results for clues to its future as a space prime.

New FDA-cleared Persona PLUS technology promises to increase plasma yields per donor, tackling the growing global demand for life-saving therapies.

Promising trial data for onvansertib offers new hope for colorectal cancer patients, yet leadership changes and financial hurdles cloud the path forward.

Navitas Semiconductor accepts short-term losses for a future in AI data centers and energy, signaling a major shift in the power electronics landscape.

All eyes are on Micron's March 18 report as a key test of the AI-fueled memory market recovery and the firm's strategic pivot to high-value tech.

Following strong Q4 earnings, Datadog will detail its AI and cloud strategy at a major conference, with investors and tech leaders watching closely.

After a major trial miss sent its stock tumbling, GRAIL will face investors to pitch its vision for the future of early cancer detection technology.

Nabsys's electronic genome mapping reveals how rogue genetic elements damage our DNA, opening new frontiers in understanding cancer and neurodegeneration.

A new solar-powered detection trailer offers a flexible, data-driven weapon against a rising tide of wrong-way crashes on America’s highways.

A newly identified blood biomarker for the drug masitinib could revolutionize how doctors treat ALS, progressive MS, and Alzheimer's disease.

Verdiva Bio's VRB-101 aims to be the first once-weekly oral GLP-1, a potential game-changer for patients tired of daily pills and injections.

A new partnership between Openly and claimtouch uses AI to automate property valuations, promising to slash settlement times and increase accuracy for homeowners.

A massive new study finds ECGs save young lives, questioning UK policy as 12 die weekly from hidden heart conditions. Is repeat screening the answer?

The insurer is expanding API integrations with major HR platforms like ADP and Workday, a strategic move to simplify benefits and gain a competitive edge.

With new backing from One Six 8 Ventures, health tech firm Respiree accelerates its US and Canadian expansion of its FDA-cleared AI platform.

An AI-native platform tackling manufacturing's biggest procurement challenges earns a coveted spot on The Hackett Group's prestigious '50 to Watch' list.

As new rules take effect, Brazil confronts a massive informal crypto economy plagued by scams and crime. Can regulation forge a path to a safer future?

At MWC Barcelona, Calnex and partners showcase live demos to de-risk Open RAN and AI RAN, proving interoperability is key to unlocking the future of networks.